Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor

por Zádor, Ferenc, Király, Kornél, Essmat, Nariman, Al-Khrasani, Mahmoud
Publicado 2022

Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening

por Poli, Giulio, Dimmito, Marilisa Pia, Mollica, Adriano, Zengin, Gokhan, Benyhe, Sandor, Zador, Ferenc, Stefanucci, Azzurra
Publicado 2019

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine

por Nagy-Grócz, Gábor, Zádor, Ferenc, Dvorácskó, Szabolcs, Bohár, Zsuzsanna, Benyhe, Sándor, Tömböly, Csaba, Párdutz, Árpád, Vécsei, László
Publicado 2017

Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

por Zádor, Ferenc, Joca, Sâmia, Nagy-Grócz, Gábor, Dvorácskó, Szabolcs, Szűcs, Edina, Tömböly, Csaba, Benyhe, Sándor, Vécsei, László
Publicado 2021

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

por Zádor, Ferenc, Nagy-Grócz, Gábor, Kekesi, Gabriella, Dvorácskó, Szabolcs, Szűcs, Edina, Tömböly, Csaba, Horvath, Gyongyi, Benyhe, Sándor, Vécsei, László
Publicado 2019

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists

por Szűcs, Edina, Stefanucci, Azzurra, Dimmito, Marilisa Pia, Zádor, Ferenc, Pieretti, Stefano, Zengin, Gokhan, Vécsei, László, Benyhe, Sándor, Nalli, Marianna, Mollica, Adriano
Publicado 2020

Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain

por Király, Kornél, Karádi, Dávid Á., Zádor, Ferenc, Mohammadzadeh, Amir, Galambos, Anna Rita, Balogh, Mihály, Riba, Pál, Tábi, Tamás, Zádori, Zoltán S., Szökő, Éva, Fürst, Susanna, Al-Khrasani, Mahmoud
Publicado 2021

Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate

por Zádor, Ferenc, Mohammadzadeh, Amir, Balogh, Mihály, Zádori, Zoltán S., Király, Kornél, Barsi, Szilvia, Galambos, Anna Rita, László, Szilvia B., Hutka, Barbara, Váradi, András, Hosztafi, Sándor, Riba, Pál, Benyhe, Sándor, Fürst, Susanna, Al-Khrasani, Mahmoud
Publicado 2020

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats

por Balogh, Mihály, Zádor, Ferenc, Zádori, Zoltán S., Shaqura, Mohammed, Király, Kornél, Mohammadzadeh, Amir, Varga, Bence, Lázár, Bernadette, Mousa, Shaaban A., Hosztafi, Sándor, Riba, Pál, Benyhe, Sándor, Gyires, Klára, Schäfer, Michael, Fürst, Susanna, Al-Khrasani, Mahmoud
Publicado 2019

On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance

por Fürst, Susanna, Zádori, Zoltán S., Zádor, Ferenc, Király, Kornél, Balogh, Mihály, László, Szilvia B., Hutka, Barbara, Mohammadzadeh, Amir, Calabrese, Chiara, Galambos, Anna Rita, Riba, Pál, Romualdi, Patrizia, Benyhe, Sándor, Timár, Júlia, Schmidhammer, Helmut, Spetea, Mariana, Al-Khrasani, Mahmoud
Publicado 2020

Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model

por Mohammadzadeh, Amir, Lakatos, Péter P., Balogh, Mihály, Zádor, Ferenc, Karádi, Dávid Árpád, Zádori, Zoltán S., Király, Kornél, Galambos, Anna Rita, Barsi, Szilvia, Riba, Pál, Benyhe, Sándor, Köles, László, Tábi, Tamás, Szökő, Éva, Harsing, Laszlo G., Al-Khrasani, Mahmoud
Publicado 2021

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors

por Mollica, Adriano, Pelliccia, Sveva, Famiglini, Valeria, Stefanucci, Azzurra, Macedonio, Giorgia, Chiavaroli, Annalisa, Orlando, Giustino, Brunetti, Luigi, Ferrante, Claudio, Pieretti, Stefano, Novellino, Ettore, Benyhe, Sandor, Zador, Ferenc, Erdei, Anna, Szucs, Edina, Samavati, Reza, Dvorácskó, Szabolcs, Tomboly, Csaba, Ragno, Rino, Patsilinakos, Alexandros, Silvestri, Romano
Publicado 2017